The CSL Group is a specialty biotechnology company with more than 90 years of experience in the development and manufacture of vaccines and plasma protein biotherapies.

Report: Partnering Deals and Alliances with CSL

CSL is a top pharmaceutical company based in Melbourne, Australia

The company was founded in 1916.

The CSL Group is a specialty biotechnology company with more than 90 years of experience in the development and manufacture of vaccines and plasma protein biotherapies.

CSL researches, develops, manufactures and markets products to treat and prevent serious human medical conditions.

The company has two core businesses; all focused on advancing innovations that provide better options and outcomes, enabling healthier lives.

Plasma Products – the company uses Human plasma to produce a wide range of life-saving medicines. The business also supports all aspects of the process from the collection and testing of donated plasma through to the production of a range of plasma-derived products.

The key businesses involved with plasma products include:

• CSL Behring:  is a global provider of plasma-derived & recombinant products. It operate one of the world's largest plasma collection networks through CSL Plasma
• CSL Behring (Australia): is the chosen national plasma fractionator of Australia, New Zealand, Hong Kong, Malaysia, Singapore and Taiwan. It also manufacture and market in vitro diagnostic products through bioCSL Immunohaematology

Vaccines & Pharmaceuticals - the company manufactures and provides influenza vaccine globally.  bioCSL also markets a comprehensive range of vaccines and antivenoms as well as a range of pharmaceutical products supplied by other manufacturers.

CSL has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. CSL has a long history of partnering, building numerous collaborative partnerships more

CSL announced 38 partnering / licensing deals since 2005, with over 14 deals in 2008 alone. Analysis of the partnering deals shows a strong emphasis on partnering in influenza vaccine followed by partnerships for development of plasma products more

CSL has also announced 2 M&A deals since 2005, with the latest deal for the acquisition of Talecris Biotherapeutics being terminated more

Report: Partnering Deals and Alliances with CSL

Examples of recent partnering and licensing deals announced CSL can be viewed in Current Partnering's Partnering Deals and Alliances with CSL partnering activity review article.

Examples of recent M&A deals announced CSL can be viewed in Current Partnering's Partnering Deals and Alliances with CSL M&A activity review article.

Our report provides more detailed insight into the details of each deal. See Partnering Deals and Alliances with CSL

Available reports from Current Partnering

Report: Partnering Deals and Alliances with CSL

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for CSL

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on CSL company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk